Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prime Editing: Mechanistic Insights and DNA Repair Modulation. | Cells | 2025 | 39996750 | PubTator, text mining | PubMed |
| UV-induced reorganization of 3D genome mediates DNA damage response. | Nat Commun | 2025 | 39910043 | PubTator, text mining | PubMed |
| Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics. | Drug Deliv Transl Res | 2025 | 39878858 | PubTator, text mining | PubMed |
| The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent. | Fundam Clin Pharmacol | 2025 | 39520092 | PubTator, text mining | PubMed |
| Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways. | Int J Cancer | 2025 | 39251783 | PubTator, text mining | PubMed |
| Keep calm and reboot - how cells restart transcription after DNA damage and DNA repair. | FEBS Lett | 2025 | 38991979 | PubTator, text mining | PubMed |
| Looping forward: exploring R-loop processing and therapeutic potential. | FEBS Lett | 2025 | 38844597 | PubTator, text mining | PubMed |
| Detecting Gene-Gene Interaction among DNA Repair Genes in Chinese non-Syndromic Cleft lip with or Without Palate Trios. | Cleft Palate Craniofac J | 2025 | 38303570 | PubTator, text mining | PubMed |
| Exploring the roles of different DNA Repair Proteins in Short Inverted Repeat Mediated Genomic Instability: A Pilot Study. | DNA (Basel) | 2024 | 41647168 | PubTator, text mining | PubMed |
| Polymorphisms in DNA Repair Genes as Biomarkers of Susceptibility for Pesticide-Induced DNA Damage among Agricultural Workers: A Review. | Indian J Occup Environ Med | 2024 | 39877282 | PubTator, text mining | PubMed |
| Beyond Nucleotide Excision Repair: The Importance of XPF in Base Excision Repair and Its Impact on Cancer, Inflammation, and Aging. | Int J Mol Sci | 2024 | 39769376 | PubTator, text mining | PubMed |
| Unveiling Secondary Mutations in Blended Phenotypes: Dual ERCC4 and OTOA Pathogenic Variants Through WES Analysis. | Int J Mol Sci | 2024 | 39769235 | PubTator, text mining | PubMed |
| Beyond Huntington's Disease - Late-Onset Chorea Caused by a Homozygous Variant in ERCC4. | Cerebellum | 2024 | 39652212 | PubTator, text mining | PubMed |
| m6A-Modified SNRPA Controls Alternative Splicing of ERCC1 Exon 8 to Induce Cisplatin Resistance in Lung Adenocarcinoma. | Adv Sci (Weinh) | 2024 | 39555714 | PubTator, text mining | PubMed |
| Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma. | Sci Rep | 2024 | 39523403 | PubTator, text mining | PubMed |
| Circ-CAMTA1 regulated by Ca2+ influx inhibited pyruvate carboxylase activity and modulate T cell function in patients with systemic lupus erythematosus. | Arthritis Res Ther | 2024 | 39473004 | PubTator, text mining | PubMed |
| Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors. | Front Med (Lausanne) | 2024 | 39421870 | PubTator, text mining | PubMed |
| Molecular architecture and functional dynamics of the pre-incision complex in nucleotide excision repair. | Nat Commun | 2024 | 39353945 | PubTator, text mining | PubMed |
| From silence to symphony: transcriptional repression and recovery in response to DNA damage. | Transcription | 2024 | 39353089 | PubTator, text mining | PubMed |
| ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer. | Pharmaceutics | 2024 | 39339159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=6